VYNE - speculating a good quarter due to FDA approval

With FDA approval already and earning reports coming through, I expect a lot of speculation that the company will have people speculating a good quarter earnings report

back

VYNE - speculating a good quarter due to FDA approval

Feb 9, 2021

bullish

general Analysis

[< 1 min Read]

blog post cover photo

With FDA approval already and earning reports coming through, I expect a lot of speculation that the company will have people speculating a good quarter earnings report

page loading card

VYNE

VYNE Therapeutics Inc.

0.45

-0.03
-7.05%

Return

-
Position Return %
0.00
Position Return
2.77
Price When Posted

Metrics

3.05
Target Price
8/ 10
Confidence
2-4 Weeks
Timeframe
catalyst icon
Earnings Release
catalyst icon
News
catalyst icon
SEC
Filing
catalyst icon
Sentiment
catalyst icon
Other Catalyst

Access the latest tools and discussion channels with an account

reddit-sentiment

Reddit Sentiment
Analysis

portfolio-balancer

Portfolio Balancer
with brokerages

sec-dashboard

SEC Dashboard
with NLP

aiodd-ad
next